JLE

Epileptic Disorders

MENU

Developmental aspects of the basal ganglia and therapeutic perspectives Volume 4, supplement 3, Supplement 3, December 2002

1. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Ann Rev Neurosci 1999; 22: 123-44.

2. Winkler C, Bentlage C, Nikkhah G, et al. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol 1999; 155: 165-86.

3. Plenz D, Kital ST. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus [see comments]. Nature 1999; 400: 677-82.

4. Bosse R, DiPaolo T. The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause. Cell Mol Neurobiol 1996; 16: 199-212.

5. Burbaud P, Bonnet B, Guehl D, et al. Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey. Brain Res 1998; 780: 102-7.

6. Iadarola MJ, Gale K. Substantia nigra: site of anticonvulsant activity mediated by o-aminobutyric acid. Science 1982; 218: 1237-40.

7. Depaulis A, Snead OCI, Marescaux C, et al. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 1989; 498: 64-72.

8. De Sarro G, Meldrum B, Reavill C. Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. Eur J Pharmacol 1984; 106: 175-9.

9. Sperber EF, Wurpel JND, Zhao DY, et al. Evidence for the involvement of nigral GABAA receptors in seizures of adult rats. Brain Res 1989; 480: 378-82.

10. Vel’s§kovà J, Vel’s§ek L, Nunes M, et al. Developmental regulation of regional functionality of substantia nigra GABAA receptors involved in seizures. Eur J Pharmacol 1996; 309: 167-73.

11. Xie XH, Tietz EI, Rosenberg HC. Anti-pentylenetetrazol effect of intranigral 2-amino-7-phosphonoheptanoate attenuated by muscimol. Brain Res 1991; 544: 331-4.

12. Turski L, Cavalheiro EA, Turski WA, et al. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-Daspartate. Neuroscience 1986; 18: 61-77.

13. Deransart C, Le-Pham BT, Hirsch E, et al. Inhibition of the substantia nigra suppresses absences and clonic seizures in audiogenic rats, but not tonic seizures: evidence for seizure specificity of the nigral control. Neuroscience 2001; 105: 203-11.

14. Lšscher W, Czuczwar SJ, JŠckel R, et al. Effect of microinjections of o-vinyl GABA or isoniazid into substantia nigra on the development of amygdala kindling in rats. Exp Neurol 1987; 95: 622-38.

15. Engel J, Jr., Wolfson L, Brown L. Anatomical correlates of electrical and behavioral events related to amygdaloid kindling. Ann Neurol 1978; 3: 538-44.

16. Eells JB, Clough RW, Miller JW, et al. Fos expression and 2-deoxyglucose uptake following seizures in developing genetically epilepsy-prone rats. Brain Res Bull 2000; 52: 379-89.

17. Nunes ML, Miller A, Vel’s§kovà J. Mapping of brain metabolism during flurothyl seizures using the [14C]-2-deoxyglucose technique. VI Workshop on Neurobiology ofEpilepsy 2001; 76.

18. Pazdernik TL, Cross RS, Giesler M, et al. Changes in local cerebral glucose utilization induced by convulsants. Neuroscience 1985; 14: 823-35.

19. Nehlig A, Vergnes M, Boyet S, et al. Metabolic activity is increased in discrete brain regions before the occurrence of spike-and-wave discharges in weanling rats with genetic absence epilepsy. Dev Brain Res 1998; 108: 69-75.

20. Sawamura A, Hashizume K, Yoshida K, et al. Kainic acidinduced substantia nigra seizure in rats: behavior, EEG and metabolism. Brain Res 2001; 911: 89-95.

21. Ingvar M. Cerebral blood flow and metabolic rate during seizures. Relationship to epileptic brain damage. Ann NY Acad Sci 1986; 462: 194-206.

22. Ingvar M. Seizure-induced damage in the substantia nigra pars reticulata: lesions in the frontal cortex prior to the seizure period mitigate the damage. Exp Brain Res 1989; 75: 369-74.

23. Towfighi J, Kofke WA, O'Connell BK, et al. Substantia nigra lesions in mercaptopropionic acid induced status epilepticus: a light and electron microscopic study. Acta Neuropathol 1989; 77: 612-20.

24. Schmidt-Kastner R, Heim C, Sontag KH. Damage of substantia nigra pars reticulata during pilocarpine-induced status epilepticus in the rat: immunohistochemical study of neurons, astrocytes and serum-protein extravasation. Exp Brain Res 1991; 86: 125-40.

25. White LE, Price JL. The functional anatomy of limbic status epilepticus in the rat. I. Patterns of 14C-2-deoxyglucose uptake and Fos immunocytochemistry. J Neurosci 1993; 13: 4787-809.

26. Labiner DM, Butler LS, Cao Z, et al. Induction of c-fos mRNA by kindled seizures: complex relationship with neuronal burst firing. J Neurosci 1993; 13: 744-51.

27. Shehab S, Julyan E. Induction of Fos-like immunoreactivity in the basal ganglia by ether anaesthesia: effects of injections of muscimol in rostral versus caudal substantia nigra pars reticulata. Exp Brain Res 2002; 142: 227-40.

28. Thompson K, Anantharam V, Behrstock S, et al. Conditionally Immortalized Cell Lines, Engineered to Produce and Release GABA, Modulate the Development of Behavioral Seizures. Exp Neurol 2000; 161: 481-9.

29. Ableitner A, Herz A. Changes in local cerebral glucose utilization induced by the beta-carbolines FG 7142 and DMCM reveal brain structures involved in the control of anxiety and seizure activity. J Neurosci 1987; 7: 1047-55.

30. Fan XD, Zhang X, Yu PH, et al. Induction of preconvulsive behavior and Fos expression by dopamine- induced nigral lesion in the rat. Brain Res 1997; 751: 31-6.

31. Haj—s M, Greenfield SA. Topographic heterogeneity of substantia nigra neurons: diversity in intrinsic membrane properties and synaptic inputs. Neuroscience 1993; 55: 919-34.

32. Bartholini G, Scatton B, Zivkovic KG, et al. GABA receptor agonists as a new therapeutic class. In: Bartholini G, Bossi L, Lloyd KG, et al. Epilepsy and GABA receptor agonists. New York: Raven Press, 1985: 1-30.

33. Meldrum BS. GABA-agonists as antiepileptic agents. In: Costa E. GABA and benzodiazepine receptor. New York: Raven Press, 1981: 207-17.

34. Jung MJ, Lippert B, Metcalf BW, et al. o-vinyl GABA (4-aminohex- 5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 1977; 29: 797-802.

35. Unnerstall JR, Kuhar MJ, Niehoff DL, et al. Benzodiazepine receptors are coupled to a subpopulation of GABA receptors: evidence from a quantitative autoradiographic study. J Pharm Exp Ther 1981; 218: 797-804.

36. Olsen RW, Snowhill EW, Wamsley JK. Autoradiographic localization of low affinity GABA receptors with [3H] bicuculline methochloride. Europ J Pharmacol 1984; 99: 247-8.

37. Palacios JM, Wamsley JK, Kuhar MJ. High affinity GABA receptors- autoradiographic localization. Brain Res 1981; 222: 285-330.

38. McCabe RT, Wamsley JK. Autoradiographic localization of subcomponents of the macromolecular GABA receptor complex. Life Sci 1986; 39: 1937-45.

39. Heyer EJ, Nowak LM, Macdonald RL. Bicuculline: a convulsant with synaptic and nonsynaptic actions. Neurology 1981; 31: 1381-90.

40. Allan RD, Dickenson HW, Duke RK, et al. ZAPA, a substrate for the neuronal high affinity GABA uptake system in rat brain slices. Neurochem Int 1991; 18: 63-7.

41. Krogsgaard-Larsen P. THIP, a specific and clinically active GABA agonist. Neuropharmacology 1984; 23: 837-8.

42. Arbilla S, Allen J, Wick A, et al. High-affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors. Eur J Pharmacol 1986; 130: 257-63.

43. Puia G, Vicini S, Seeburg PH, et al. Influence of recombinant o-aminobutyric acidA receptor subunit composition on the action of allosteric modulators of o-aminobutyric acid-gated Cl- currents. Mol Pharmacol 1991; 39: 691-6.

44. Vel’s§kovà J, Lšscher W, Moshé SL. Regional and age specific effects of zolpidem microinfusions in the substantia nigra on seizures. Epilepsy Res 1998; 30: 107-14.

45. Saxena NC, Macdonald RL. Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms. Mol Pharmacol 1996; 49: 567-79.

46. Sigel E, Baur R, Trube G, et al. The effect of subunit composition of rat brain GABAA receptors on channel function. Neuron 1990; 5: 703-11.

47. Verdoorn A, Draguhn A, Ymer S, et al. Functional properties of recombinant rat GABAA receptors depend upon subunit composition. Neuron 1990; 4: 919-28.

48. Wafford K, Whiting P, Kemp J. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant o- aminobutyric acid A receptor subtypes. Mol Pharmacol 1992; 43: 240-4.

49. Levitan ES, Schofield PR, Burt DR, et al. Structural and functional basis for GABAA receptor heterogeneity. Nature 1988; 335: 76-9.

50. Vel’s§kovà J, Kubovà H, Friedman LK, et al. The expression of GABAA receptor subunits in the substantia nigra is developmentally regulated and region-specific. Ital J Neurol Sci 1998; 19: 205-10.

51. Moshé SL, Brown LL, Kubovà H, et al. Maturation and segregation of brain networks that modify seizures. Brain Res 1994; 665: 141-6.

52. Wisden W, Laurie DJ, Monyer H, et al. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992; 12: 1040-62.

53. Schwarzer C, Berresheim U, Pirker S, et al. Distribution of the major gamma-aminobutyric acid(A) receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat. J Comp Neurol 2001; 433: 526-49.

54. Vel’s§kovà J, Fabiànovà K, Liptàkovà S. Gender differences in the GAD67 immunoreactivity in the substantia nigra pars reticulata. Epilepsia 1998; 39: 28.

55. Galanopoulou A, Moshé SL. Sex differences in the expression of the potassium-chloride cotransporter 2 (KCC2) mRNA in the substantia nigra reticulata of developing rats. Soc Neurosci Abst 2001; 27: Program No. 263.9.

56. Rivera C, Voipio J, Payne JA, et al. The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 1999; 397: 251-5.

57. Garcia-Cairasco N, Terra VC, Doretto MC. Midbrain substrates of audiogenic seizures in rats. Behav Brain Res 1993; 58: 57-67.

58. Gale K. Role of the substantia nigra in GABA-mediated anticonvulsant actions. Adv Neurol 1986; 44: 343-64.

59. Depaulis A, Liu Z, Vergnes M, et al. Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus. Epilepsy Res 1990; 5: 192-8.

60. Gale K, Pazos A, Maggio R, et al. Blockade of GABA receptors in superior colliculus protects against focally evoked limbic motor seizures. Brain Res 1993; 603: 279-83.

61. Redgrave P, Marrow L, Dean P. Anticonvulsant role of nigrotectal projection in the maximal electroshock model of epilepsy - II. Pathways from substantia nigra pars lateralis and adjacent peripeduncular area to the dorsal midbrain. Neuroscience 1992; 46: 391-406.

62. Vel’s§kovà J, Moshé SL. Sexual dimorphism and developmental regulation of substantia nigra function. Ann Neurol 2001; 50: 596-601.

63. Garant DS, Xu SG, Sperber EF, et al. Age-related differences in the effects of GABAA agonists microinjected into rat substantia nigra: pro- and anticonvulsant actions. Epilepsia 1995; 36: 960-5.

64. Ojeda SR, Urbanski HF. Puberty in the rat. In: Knobil E, Neil J. The Physiology ofReproduction . New York: Raven Press, Ltd., 1994: 363-409.

65. Xu SG, Garant DS, Sperber EF, et al. The proconvulsant effect of nigral infusions of THIP on flurothyl-induced seizures in rat pups. Dev Brain Res 1992; 68: 275-7.

66. Sperber EF, Wong BY, Wurpel JN, et al. Nigral infusions of muscimol or bicuculline facilitate seizures in developing rats. Brain Res 1987; 465: 243-50.

67. Wurpel JND, Tempel A, Sperber EF, et al. Age-related changes of muscimol binding in the substantia nigra. Dev Brain Res 1988; 43: 305-8.

68. Claudio OI, Kyrozis A, Moshé SL. Muscimol depolarizes male and hyperpolarizes female substantia nigra pars reticulata neurons. Epilepsia 2001; 42: 12.

69. McEwen BS, Alves SE, Bulloch K, et al. Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol Bull 1998; 34: 251-9.

70. Bixo M, Backstrom T, Winblad B, et al. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 1995; 55: 297-303.

71. Lyons KE, Hubble JP, Troster AI, et al. Gender differences in Parkinson's disease. Clin Neuropharmacol 1998; 21: 118-21.

72. Miller DB, Ali SF, O'Callaghan JP, et al. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann NY Acad Sci 1998; 844: 153-65.

73. Rivest R, Falardeau P, Di Paolo T. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 1995; 692: 269-72.

74. Vadasz C, Baker H, Fink SJ, et al. Genetic effects and sexual dimorphism in tyrosine hydroxylase activity in two mouse strains and their reciprocal F1 hybrids. J Neurogenet 1985; 2: 219-30.

75. Guivarc'h D, Vernier P, Vincent JD. Sex steroid hormones change the differential distribution of the isoforms of the D2 dopamine receptor messenger RNA in the rat brain. Neuroscience 1995; 69: 159-66.

76. Wilson MA. Gonadectomy and sex modulate spontaneous activity of substantia nigra pars reticulata neurons without modifying GABA/benzodiazepine responsiveness. Life Sci 1993; 53: 217-25.

77. Manev H, Pericic D. Sex difference in the turnover of GABA in the rat substantia nigra. J Neural Transm 1987; 70: 321-8.

78. Canonaco M, Tavolaro R, Facciolo RM, et al. Sexual dimorphism of GABAA receptor levels in subcortical brain regions of a woodland rodent (Apodemus sylvaticus). Brain Res Bull 1996; 40: 187-94.

79. Nicoletti F, Patti F, Ferrara N, et al. Comparative effects of estrogens and prolactin on nigral and striatal GAD activity. Brain Res 1982; 232: 238-41.

80. Gernert M, Loscher W. Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats. Eur J Pharmacol 2001; 432: 35-41.

81. Pfaff DW. Morphological changes in the brains of adult male rats after neonatal castration. J Endocrin 1966; 6: 415-6.

82. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th. New York: Academic Press, 1998.